AONC (American Oncology Network) Marketable Securities: $10 Mil (As of Dec. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AONC American Oncology Network Inc AONC
20 GF Score
Price $12.00
View Full Analysis

What is American Oncology Network Marketable Securities?

American Oncology Network AONC +20.00% 20 Marketable Securities is $10 Mil as of Dec. 2024. GuruFocus rates AONC with a GF Score™ of 20/100.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. American Oncology Network's Marketable Securities for the quarter that ended in Dec. 2024 was $10 Mil.

American Oncology Network's annual Marketable Securities increased from Dec. 2022 ($10 Mil) to Dec. 2023 ($35 Mil) but then declined from Dec. 2023 ($35 Mil) to Dec. 2024 ($10 Mil).

American Oncology Network  (OTCPK:AONC) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

American Oncology Network Marketable Securities Related Terms

American Oncology Network Marketable Securities Historical Data

* Premium members only.

The historical data trend for American Oncology Network's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

American Oncology Network Marketable Securities Chart

American Oncology Network Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Marketable Securities
0.00 0.00 9.85 35.39 9.79

American Oncology Network Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 35.39 30.11 21.39 0.00 9.79
AONC
20GF Score
American Oncology Network Inc AONC
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

American Oncology Network Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $10 Mil mean?
American Oncology Network (AONC) has a Marketable Securities of $10 Mil as of Dec. 2024. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on American Oncology Network and its competitors.
Is American Oncology Network's Marketable Securities too high?
American Oncology Network's current Marketable Securities is $10 Mil. Overall, American Oncology Network has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does American Oncology Network's Marketable Securities compare to TOI and AUNA?
American Oncology Network's Marketable Securities of $10 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on American Oncology Network and its competitors. American Oncology Network's current Marketable Securities is $10 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is American Oncology Network stock overvalued right now?
American Oncology Network (AONC) has a current Marketable Securities of $10 Mil. The current Marketable Securities is $10 Mil. American Oncology Network's overall GF Score™ is 20/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For American Oncology Network (AONC), the current Marketable Securities is $10 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

American Oncology Network Business Description

Address 14543 Global Parkway, Suite 110, Fort Myers, FL, USA, 33913
American Oncology Network Inc through its subsidiary companies and variable interest entities, is an alliance of physicians and seasoned healthcare leaders who provide comprehensive oncology services across 37 oncology practices located in twenty states. The Company also provides expertise in drug procurement and payor contracting, along with practice diversification through centralized laboratory and pathology services, as well as specialty pharmacy services, clinical research, radiation oncology, and imaging.
20GF Score

Get the complete analysis for AONC

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.00
Price